5 completed, 5 terminated, 4 active not recruiting, 4 recruiting. 8 Phase 2, 7 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 3, Active not recruiting 2, Completed 2, Withdrawn 1 |
| Phase 1 | 7 | Completed 2, Terminated 2, Withdrawn 2, Recruiting 1 |
Follow Peripheral blood draw: new trials by email Literature Review of Peripheral blood draw trials Research Report on Peripheral blood draw
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Validation of the Oncoliq Test for the Early Detection of Breast Cancer. Peripheral blood draw - Breast Cancer Detection, Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Recruiting | Oncoliq US Inc | 300 | 2025-10-17 | 2026-01-15 | |
| Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors Personalized neoantigen DNA vaccine, Papivax Biotech TDS-IM v2.0, Peripheral blood draw - Pediatric Recurrent Central Nervous System Tumors | Phase 1 | Recruiting | Washington University School of Medicine | 7 | 2024-10-02 | 2026-05-07 |
| Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors Personalized peptide vaccine, Poly ICLC, Peripheral blood draw - Pediatric Brain Tumor | Phase 1 | Withdrawn | Washington University School of Medicine | 2021-09-30 | 2021-05-25 | |
| Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma Olaparib, Pembrolizumab, Carboplatin - Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma | Phase 2 | Active not recruiting | Washington University School of Medicine | 30 | 2021-08-07 | 2026-10-27 |
| Duvelisib to Combat COVID-19 Duvelisib, Peripheral blood draw, Placebo - COVID-19 | Phase 2 | Completed | Washington University School of Medicine | 28 | 2020-10-12 | 2023-03-06 |
| Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas Duvelisib, Peripheral blood draw - T-Cell Lymphoma | Phase 2 | Terminated | Washington University School of Medicine | 17 | 2020-07-23 | 2026-05-06 |
| Ruxolitinib to Combat COVID-19 Ruxolitinib, Peripheral blood draw - COVID-19 | Phase 2 | Withdrawn | Washington University School of Medicine | 2020-06-30 | 2020-05-21 | |
| The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines nasal pharyngeal (NP) swab samples, peripheral blood draw - SARS-CoV-2 | Unknown | Invivoscribe, Inc. | 500 | 2020-06-01 | 2020-05-18 | |
| AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration Peripheral blood draw, Bone marrow aspirate, Buccal swab - Acute Myeloid Leukemia, Myelodysplastic Syndromes | Active not recruiting | Washington University School of Medicine | 80 | 2020-01-29 | 2026-03-02 | |
| Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy Durvalumab, Neoantigen DNA vaccine, TDS-IM system (Inchor Medical Systems) - Triple Negative Breast Cancer, Triple Negative Breast Neoplasms | Phase 1 | Terminated | Washington University School of Medicine | 18 | 2019-07-23 | 2024-05-28 |
| Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC Ramucirumab, Atezolizumab, Peripheral blood draw - Non-small Cell Lung Cancer, Non Small Cell Lung Cancer | Phase 2 | Completed | Washington University School of Medicine | 21 | 2019-06-05 | 2024-07-30 |
| The Role of Pyroptosis in Chronic Venous Disease Peripheral blood draw - Inflammation, Veins | Unknown | University of Catanzaro | 400 | 2018-11-12 | 2018-11-16 | |
| Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma Palbociclib, Cetuximab, Cisplatin - Head and Neck Squamous Cell Carcinoma | Phase 2 | Active not recruiting | Washington University School of Medicine | 26 | 2018-04-27 | 2026-04-21 |
| Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis Pevonedistat, Ruxolitinib, Peripheral blood draw - Myelofibroses | Phase 1 | Terminated | Washington University School of Medicine | 8 | 2018-04-23 | 2022-01-06 |
| Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant For Step 2: Structured treatment interruption, Peripheral blood draw - HIV-1-infection | Phase 1 | Withdrawn | Washington University School of Medicine | 2018-03-19 | 2018-11-07 | |
| Minimal Residual Disease in Peripheral T-cell Lymphoma Tumor biopsy, Peripheral blood draw, Lymphotrack TCR clonality assay - Peripheral T Cell Lymphoma | Completed | Washington University School of Medicine | 44 | 2017-07-31 | 2024-05-16 | |
| Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia Decitabine, Bone marrow biopsy/aspirate, Peripheral blood draw - Acute Myeloid Leukemia, Acute Myeloid Leukemia, Relapsed, Adult | Phase 2 | Terminated | Washington University School of Medicine | 17 | 2017-07-14 | 2022-06-02 |
| CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia CX-01, Azacitidine, Bone marrow biopsy - Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 1 | Completed | Washington University School of Medicine | 20 | 2017-04-07 | 2019-12-05 |
| Shave Margins in Breast Conservation Therapy Breast-conserving surgery (BCS), Cavity shave margins (CSM), BREAST-Q Questionnaire - Breast Cancer, Cancer of Breast | Phase 2 | Terminated | Washington University School of Medicine | 81 | 2016-06-13 | 2020-06-25 |
| Aging, Geriatric Syndromes and Clonal Hematopoiesis Cognitive Assessment, Activities of Daily Living Questionnaire, Instrumental Activities of Daily Living, subscale of the OARS - Geriatrics, Aged | Recruiting | Washington University School of Medicine | 2000 | 2016-03-10 | 2026-07-13 |
Showing 20 of 23. Sign in to see all of them.
Breast Neoplasms (3) · Leukemia, Myeloid, Acute (3) · COVID-19 (2) · Myelodysplastic Syndromes (2) · Squamous Cell Carcinoma of Head and Neck (2) · Bronchiolitis Obliterans Syndrome (1) · Carcinoma, Non-Small-Cell Lung (1) · Cardiovascular Diseases (1) · Endometrial Neoplasms (1) · Inflammation (1) · Lymphoma, T-Cell (1) · Lymphoma, T-Cell, Peripheral (1) · Primary Myelofibrosis (1) · Recurrence (1) · Triple Negative Breast Neoplasms (1)
Washington University School of Medicine (20) · Invivoscribe, Inc. (1) · Oncoliq US Inc (1) · University of Catanzaro (1)
United States (17) · Argentina (1) · Italy (1)
John DiPersio, M.D., Ph.D. (2) · Meagan Jacoby, M.D. (2) · Amanda Cashen, M.D. (1) · Daniel Morgensztern, M.D. (1) · Douglas Adkins, M.D. (1) · Douglas R Adkins, M.D. (1) · Eynav Klechevsky, Ph.D. (1) · John Welch, M.D., Ph.D. (1) · Jordon Thornes (1) · Joshua Rubin, M.D., Ph.D. (1) · Julie Margenthaler, M.D. (1) · Michael A Huang, M.D. (1) · Neha Mehta-Shah, M.D. (1) · Peter Westervelt, M.D., Ph.D. (1) · Premal Thaker, M.D., MSc. (1)
PMID 28453704, PMID 34409776, PMID 37953814
K12CA167540 (1), P50CA171963 (1), R01CA240983 (1)